Helen Torley - Feb 10, 2023 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
PRESIDENT AND CEO, Director
Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Feb 10, 2023
Transactions value $
-$1,650,316
Form type
4
Date filed
2/14/2023, 04:17 PM
Previous filing
Feb 9, 2023
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +31.3K +5.33% $0.00 618K Feb 10, 2023 Direct
transaction HALO Common Stock Tax liability -$806K -16.5K -2.66% $48.92 602K Feb 10, 2023 Direct F1
transaction HALO Common Stock Options Exercise $0 +32.8K +5.45% $0.00 635K Feb 12, 2023 Direct
transaction HALO Common Stock Tax liability -$845K -17.3K -2.72% $48.92 618K Feb 12, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -31.3K -50% $0.00 31.3K Feb 10, 2023 Common Stock 31.3K $0.00 Direct F3
transaction HALO Restricted Stock Units Options Exercise $0 -32.8K -100% $0.00* 0 Feb 12, 2023 Common Stock 32.8K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 16,469 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
F2 The reported disposition of 17,266 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
F3 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.